Ask AI
ProCE Banner Activity

Immunotherapy Options for Nonmetastatic NSCLC

Slideset Download
Download this slideset from a live CCO symposium for an overview of the key data on immunotherapy options for patients with early-stage resectable and stage III unresectable NSCLC.

Released: November 10, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Zofia Piotrowska, MD, MHS

Associate Professor of Medicine, Harvard Medical School
Clinical Co-Director, MGB Thoracic Medical Oncology Program
Mass General Brigham Cancer Institute
Boston, Massachusetts